Header cover image

Dutch (AEX) Biotech Industry Analysis

UpdatedJul 29, 2026
DataAggregated Company Financials
Companies3
  • 7D-4.0%
  • 3M-6.8%
  • 1Y-2.1%
  • YTD-16.8%

Over the last 7 days, the Biotech industry has dropped 5.1%, driven by pullbacks from every company within the industry. As for the longer term, the industry's performance has been flat for the past year. Looking forward, earnings are forecast to decline by 2.4% per year.

Industry Valuation and Performance

Has the Dutch Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 29 Jul 2026€2.4b€1.4b€489.9m37.5x5x1.8x
Fri, 26 Jun 2026€2.5b€1.4b€489.9m39.7x5.2x1.8x
Sun, 24 May 2026€2.4b€1.4b€489.7m38.7x4.9x1.8x
Tue, 21 Apr 2026€2.7b€1.4b€309.4m219.9x8.8x1.9x
Thu, 19 Mar 2026€2.8b€1.4b€309.5m187x9.1x2x
Sat, 14 Feb 2026€2.8b€592.1m-€456,033,203.202833.9x-6.2x4.8x
Mon, 12 Jan 2026€3.0b€598.3m-€456,026,709.203364.3x-6.6x5x
Wed, 10 Dec 2025€2.8b€598.2m-€456,026,785.603045.7x-6.2x4.8x
Fri, 07 Nov 2025€2.8b€570.1m-€308,037,940.00n/a-8.9x4.8x
Sun, 05 Oct 2025€3.1b€565.1m-€307,915,760.00n/a-10x5.5x
Tue, 02 Sep 2025€2.7b€565.7m-€316,017,340.00n/a-8.5x4.7x
Thu, 31 Jul 2025€2.5b€556.3m-€321,369,233.60n/a-7.9x4.5x
Sat, 28 Jun 2025€2.3b€562.2m-€211,961,881.60n/a-10.6x4x
Mon, 26 May 2025€2.4b€570.5m-€212,328,793.60n/a-11.1x4.1x
Wed, 23 Apr 2025€1.9b€535.8m-€11,646,427.30n/a-166.1x3.6x
Fri, 21 Mar 2025€2.1b€549.5m-€11,443,380.50n/a-185x3.9x
Sun, 16 Feb 2025€2.2b€548.0m-€18,267,319.00n/a-118.1x3.9x
Tue, 14 Jan 2025€2.2b€539.8m-€78,059,717.00n/a-27.8x4x
Thu, 12 Dec 2024€2.3b€531.9m-€77,566,019.90n/a-29.3x4.3x
Sat, 09 Nov 2024€2.2b€526.7m-€77,239,859.00n/a-27.9x4.1x
Mon, 07 Oct 2024€2.2b€514.3m€19.4m54.4x114.1x4.3x
Wed, 04 Sep 2024€2.2b€512.8m€19.4m55x113x4.3x
Fri, 02 Aug 2024€2.1b€483.0m€20.7m53.6x103.4x4.4x
Sun, 30 Jun 2024€2.0b€484.8m€20.6m50.1x99.1x4.2x
Tue, 28 May 2024€2.2b€481.5m€20.8m54.2x107x4.6x
Thu, 25 Apr 2024€2.4b€468.9m-€13,844,051.20n/a-173.1x5.1x
Sat, 23 Mar 2024€2.7b€466.7m-€39,641,122.60n/a-68.6x5.8x
Mon, 19 Feb 2024€3.4b€747.0m-€199,827,245.50n/a-16.8x4.5x
Wed, 17 Jan 2024€3.3b€745.2m-€199,646,395.00n/a-16.6x4.4x
Fri, 15 Dec 2023€3.4b€742.8m-€199,410,406.00n/a-16.9x4.5x
Sun, 12 Nov 2023€3.1b€748.7m-€199,999,275.00n/a-15.6x4.2x
Tue, 10 Oct 2023€3.2b€755.3m-€199,168,712.00n/a-16.1x4.2x
Thu, 07 Sep 2023€3.3b€752.7m-€200,822,278.00n/a-16.7x4.4x
Sat, 05 Aug 2023€3.7b€747.0m-€200,424,992.00n/a-18.3x4.9x
Price to Earnings Ratio

-18.3x


Total Market Cap: €3.7bTotal Earnings: -€200,424,992.00Total Revenue: €747.0mTotal Market Cap vs Earnings and Revenue0%0%0%
Dutch Biotech Industry Price to Earnings3Y Average -3.8x202420252026
Current Industry PE
    There are only 3 companies in the Dutch Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 23% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the Dutch Healthcare industry?

NL Market-5.09%
Healthcare-3.99%
Biotech-4.03%
Biotech-4.03%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available